Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009167HBVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20012030HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20036049HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20056806HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS44025067HTLV-1ENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TCGA Plot Options
Drug Information
GeneSCN5A
DrugBank IDDB01056
Drug NameTocainide
Target IDBE0000197
UniProt IDQ14524
Regulation Typeinhibitor
PubMed IDs10953551; 11752352
CitationsGeorgijevic Milic L: [Molecular genetics in the hereditary form of long QT syndrome]. Med Pregl. 2000 Jan-Feb;53(1-2):51-4.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct Classificationm-Xylenes
SMILESCC(N)C(=O)NC1=C(C)C=CC=C1C
PathwaysTocainide Action Pathway
PharmGKBPA451706
ChEMBLCHEMBL1762